Patents by Inventor Herwig Reichl

Herwig Reichl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9364437
    Abstract: The present invention relates to pharmaceutical compositions, food supplement compositions and cosmetic compositions comprising diaminooxidase, and to the use thereof.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: June 14, 2016
    Assignee: SCIOTEC DIAGNOSTIC TECHNOLOGIES GMBH
    Inventors: Albert Missbichler, Franz Gabor, Herwig Reichl
  • Publication number: 20140220148
    Abstract: The present invention relates to pharmaceutical compositions, food supplement compositions and cosmetic compositions comprising diaminooxidase, and to the use thereof.
    Type: Application
    Filed: April 4, 2014
    Publication date: August 7, 2014
    Applicant: SCIOTEC DIAGNOSTIC TECHNOLOGIES GMBH
    Inventors: Albert MISSBICHLER, Franz GABOR, Herwig REICHL
  • Patent number: 8716244
    Abstract: The present invention relates to pharmaceutical compositions, food supplement compositions and cosmetic compositions comprising diaminooxidase, and to the use thereof.
    Type: Grant
    Filed: August 24, 2010
    Date of Patent: May 6, 2014
    Assignee: Sciotec Diagnostic Technologies GmbH
    Inventors: Albert Missbichler, Franz Gabor, Herwig Reichl
  • Publication number: 20100330191
    Abstract: The present invention relates to pharmaceutical compositions, food supplement compositions and cosmetic compositions comprising diaminooxidase, and to the use thereof.
    Type: Application
    Filed: August 24, 2010
    Publication date: December 30, 2010
    Inventors: Albert Missbichler, Franz Gabor, Herwig Reichl
  • Publication number: 20080193491
    Abstract: The present invention relates to pharmaceutical compositions, food supplement compositions and cosmetic compositions comprising diaminooxidase, and to the use thereof.
    Type: Application
    Filed: July 6, 2005
    Publication date: August 14, 2008
    Inventors: Albert Missbichler, Franz Gabor, Herwig Reichl
  • Publication number: 20020147137
    Abstract: Disclosed is the use of &agr;1-acid glycoprotein (AAG) for the preparation of a medicament for influencing and accelerating drug withdrawal, as well as a kit comprising &agr;1-acid glycoprotein and a plasmapheresis set for further plasma exchange with plasma and/or serum albumin solution.
    Type: Application
    Filed: October 15, 2001
    Publication date: October 10, 2002
    Applicant: Hamosan Erzeugung Pharmazeutischer Grundstoffe Gesellschaft M.B.H.
    Inventors: Konstantin Hiotakis, Herwig Reichl
  • Patent number: 5633349
    Abstract: A method for the inactivation of prions, viruses and other infectious agents, which might be present in a biological raw material (e.g. plasma for the preparation of albumin), leaving the desired biological product (e.g. BSA, HSA) intact. To achieve this, the biological raw material is treated with a chaotropic agent, e.g. urea or siodium thiocyanate for approx. 18 hours. Before this, a detergent, e.g. sodium dodecyl sulfate, as well as ethanol or methanol can be added, and the solution can be heated to 70.degree. C. and kept at this temperature for 30 minutes. After cooling and acidification, denatured globulins can be removed. By modifications of this process (e.g. different concentrations, pH-values, temperatures etc.) a wide range of biological products (serum, plasma, proteins, peptides, gangliosides etc.) can be treated and rendered free of viruses, prions and all other infectivity.
    Type: Grant
    Filed: September 2, 1994
    Date of Patent: May 27, 1997
    Inventor: Herwig Reichl